The Therapeutic Goods Administration (TGA) today confirmed in its COVID-19 vaccine weekly safety report that a 44-year-old man from Tasmania and a 48-year-old woman in Victoria had died.
Both cases were confirmed to have had thrombosis with thrombocytopenia syndrome – or TTS – which is triggered by the immune system's response to the AstraZeneca vaccine and is different from other clotting conditions.
"Sadly, this week we were notified that two confirmed cases of TTS after the first dose of the AstraZeneca vaccine were fatal," the TGA noted in its report.
"One was in a 44-year-old man from Tasmania and the other was in a 48-year-old woman from Victoria (this case was reported as probable TTS in last week's report).
"The TGA extends its sincerest condolences to their families and loved ones."
[Image: https://i.gifer.com/7ZqO.gif]